Blog

Education · 6 min read

Is Compounded Semaglutide Available in California?

Yes — compounded semaglutide is available to eligible California residents through licensed telehealth. Who qualifies, how it's legally different from a brand-name prescription, where it comes from, and how to verify a provider.

Reviewed byPallas Clinical TeamAug 11, 20266 min read

Yes — compounded semaglutide is available to eligible California residents through licensed telehealth. It's prepared per-patient by a US-licensed compounding pharmacy under FDCA §503A, and a California-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale, not cost or preference alone. It's available alongside FDA-approved brand-name options like Wegovy® and Ozempic® through the same intake. See the California state page for current specifics, or read on for who qualifies and how the compounded pathway actually works.

The short answer

Compounded semaglutide is legally available to eligible California residents when a California-licensed clinician documents a patient-specific reason it's appropriate for you, and a US-licensed 503A (or 503B) compounding pharmacy prepares it. Availability isn't automatic or guaranteed for everyone — it's a clinical decision made after a real intake review, the same as any prescription.

Yes, within a specific framework. Compounded semaglutide is legal in California when three conditions are met: a California-licensed clinician (physician or nurse practitioner with prescriptive authority) reviews your health history and documents a patient-specific clinical rationale for compounding rather than defaulting to a brand-name product; a US-licensed compounding pharmacy — regulated under federal law (FDCA §503A) and by state boards of pharmacy — prepares the medication for you individually; and you receive it only after that review, never before it.

Compounded medications are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.

Who's eligible for compounded semaglutide in California?

Eligibility is a clinical decision made by your California-licensed clinician after reviewing your full intake — never an automatic quiz result. As a general guide, GLP-1 medications for weight management are considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher together with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea. Your clinician also reviews your medical history and current medications for contraindications — a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, current or planned pregnancy, and a history of pancreatitis are common reasons treatment isn't appropriate. Specifically for the compounded tier, your clinician additionally has to document why a compounded preparation, rather than an FDA-approved product, fits your situation — that's a separate judgment from whether a GLP-1 is right for you at all.

Check your eligibility in California

Complete a short health questionnaire and a California-licensed clinician will review whether compounded or brand-name semaglutide is appropriate for you — most patients never need to schedule a video call.

Start your intake →

How is compounded semaglutide different from getting Wegovy® in California?

Procedurally, not clinically — both go through the exact same California-licensed clinician review before anything is prescribed. What differs is where the medication itself comes from and how it's regulated. FDA-approved Wegovy® and Ozempic® are commercially manufactured by Novo Nordisk and dispensed by a retail or mail-order pharmacy, the same product sold anywhere in the country. Compounded semaglutide is prepared individually for you by a US-licensed compounding pharmacy under §503A, only after your clinician documents that specific rationale. Compounded semaglutide is not FDA-approved and is not a generic version of Wegovy® or Ozempic® — it's a distinct, separately regulated preparation, and your clinician decides which pathway fits your history, not which one is easier to get. For the fuller national comparison of the two tiers, see compounded vs. brand-name GLP-1s.

Where does compounded semaglutide in California actually come from?

A specific, named pharmacy — never a warehouse shipping unlabeled vials. Once your California-licensed clinician prescribes compounded semaglutide, a US-licensed 503A (or 503B) compounding pharmacy prepares your dose individually against that prescription and ships it to you; Pallas works only with pharmacies that meet those licensing requirements. A legitimate telehealth provider can always tell you which specific pharmacy prepares your medication — if a source can't or won't answer that question, that alone is disqualifying, regardless of price. For how to independently verify a pharmacy's California license, see our guide to what compounded semaglutide costs in California, which covers the California State Board of Pharmacy lookup in detail.

Is compounded semaglutide available across all of California?

Yes. Eligibility, the clinician review, and the compounding pathway itself don't vary by ZIP code — a resident in Los Angeles, San Diego, the Bay Area, or Sacramento goes through the identical intake, the identical California-licensed clinician review, and the identical §503A framework as anyone in a smaller California town. What can vary slightly is how quickly you complete your own intake and how fast a package reaches you; the eligibility standard and the legal pathway are statewide, not metro-specific. For the full state-by-state overview of how the process starts, see how to get a GLP-1 prescription online in California.

How do I verify a compounded semaglutide provider is legitimate in California?

Four checks cover most of it:

  • A California-licensed clinician, verifiable. Prescriptions for California residents require a clinician independently licensed by the Medical Board of California, or a nurse practitioner with active California prescriptive authority — check the Medical Board of California's license lookup.
  • A named, licensed compounding pharmacy. A legitimate provider can tell you exactly which US-licensed 503A or 503B pharmacy prepares your medication, and you can look it up through the California State Board of Pharmacy.
  • A real intake and clinical rationale — not a checkout button. A site that lets you skip straight to payment with no health questionnaire and no documented reason for compounding isn't practicing medicine in California, however it's marketed.
  • Verifiable LegitScript certification. LegitScript maintains a public database of certified healthcare merchants. Pallas is LegitScript Healthcare Merchant Certified, and you can look up any provider before paying.

Two labels are reliable red flags wherever you see them: vials marked "for research use only" (not pharmaceutical products prepared for human use, and not dispensed by licensed pharmacies) and any seller willing to ship without a prescription at all.

The bottom line

Compounded semaglutide is available to eligible California residents, but "available" means through a real clinical pathway — a California-licensed clinician documenting a patient-specific rationale, and a named US-licensed 503A or 503B pharmacy preparing it — not an automatic yes for anyone who asks. The legal framework and eligibility standard are the same everywhere in the state, and the same pathway sits alongside FDA-approved brand-name options through the same intake. Learn more about GLP-1 treatment at Pallas or check current specifics on the California state page.

Frequently asked questions

Yes — compounded semaglutide is available to eligible California residents through licensed telehealth. It's prepared per-patient by US-licensed compounding pharmacies under FDCA §503A, and a California-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale. FDA-approved brand-name options like Wegovy® and Zepbound® are also available through the same intake.

Eligibility is decided by a California-licensed clinician after reviewing your full intake, never by an automated quiz. In general, GLP-1 medications for weight management are considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher together with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea. For the compounded tier specifically, your clinician must also document a patient-specific reason a compounded preparation is appropriate for you, separate from whether a GLP-1 is right for you at all.

No. Compounded semaglutide is not FDA-approved and is not a generic version of Wegovy® or Ozempic® — it's prepared per-patient by a US-licensed compounding pharmacy under §503A, a separately regulated pathway from the commercially manufactured brand-name products. The clinician review that precedes a prescription is the same either way; the medication and its regulatory status are not.

Yes. Both the semaglutide shortage (resolved February 21, 2025) and the tirzepatide shortage (resolved December 19, 2024) have ended, so shortage status no longer justifies a compounded prescription. Under FDCA §503A(b)(1)(C), a California-licensed clinician can prescribe a compounded preparation only after documenting a patient-specific clinical rationale — not for price or preference alone.

Everywhere in the state. Eligibility, the clinician review, and the §503A compounding pathway don't vary by ZIP code — the process is identical whether you're in Los Angeles, San Diego, the Bay Area, Sacramento, or a smaller California town. What can vary is only how quickly you complete your own intake.

Check the prescribing clinician's California license through the Medical Board of California's license lookup, confirm the specific compounding pharmacy's license through the California State Board of Pharmacy, and verify the company's LegitScript Healthcare Merchant Certification in LegitScript's public database. A provider that won't name its clinician or its pharmacy, or that skips a real health questionnaire, fails all three checks regardless of price.

See if compounded semaglutide fits you

A California-licensed clinician reviews your intake and lets you know if compounded or brand-name treatment is appropriate for you. No insurance needed, cancel anytime.

Start your intake →

Trademarks & disclosures

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Pallas is not affiliated with, endorsed by, or sponsored by either manufacturer. Brand-name GLP-1 medications dispensed through Pallas are cash-pay only and are not billed to insurance. Prescriptions — brand-name or compounded — are written only when a California-licensed clinician determines treatment is appropriate.